The European Medicines Agency on Friday recommended authorizing Moderna's COVID-19 vaccine for children ages 12 to 17, the first time the shot has been authorized for people under 18.
The EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna vaccine already given the OK for adults across Europe produced a comparable antibody response.